Leveraging the Learnings from Oncology: Delve into in vivo Generation of CAR-T Cells to Reduce Fibrosis & Restore Cardiac Function

Time: 2:00 pm
day: Conference Day 1


  • The promise in vivo generation CAR-T cells hold as a therapeutic platform to treat cardiovascular disease
  • Understanding the use of modified mRNA targeted LNPs to reduce fibrosis and restore cardiac function
  • Evaluating efficacy using a mouse model of heart failure